Why the C-HR is Toyota's secret weapon
When considering buying any new car, it's a strange thing but we often suddenly see that model everywhere. So it is sometimes with vehicles I find myself driving. That absolutely has applied to the latest Toyota C-HR, the two-tone crossover with origami-like lines, during a week of testing one. I even found myself peering at any example to see if it might be the same as 'mine', the new-ish PHEV.
You can pick out the plug-in hybrid by an extra flap, that being a cover for the charging socket. Other than that, different instrumentation, a smaller boot and no base model grade, it's tricky to tell the newest addition from the existing HEV variants.
Built exclusively at Toyota Motor Manufacturing Türkiye's Adapazarı plant, the 4.4 m long front- or all-wheel drive C-HR is in its second generation, having premiered just short of two years ago. In fact it had also been a concept before that.
Facelift coming? Not for a while
As the original was around for seven years, generation three shouldn't arrive until the end of 2030 (first or second quarters of 2031 for the UK). A facelift for the existing model can be expected to be announced in about 18 months' time.
TMMT started manufacturing the latest shape car in November 2023. At first it was hybrid only, with 1.8-litre variants being front-wheel drive and 2.0-litre ones also offering an AWD option. Now there is a third powertrain in the form of the 2.0-litre PHEV. Power is 164 kW (223 PS) compared to 145 kW (197 PS) for the 2.0-litre hybrid and just 103 kW/140 PS for the 1.8 HEV. In the PHEV the motor alone produces 120 kW while the engine's power is 112 kW.
Battery adds a lot of mass
There are a couple of disadvantages to the plug-in hybrid, that being a 200 kilo weight penalty courtesy of the battery which is at least positioned close to the car's middle. And while that's great for distribution of mass, the handling suffers a little. Components associated with the PHEV system also mean the boot's capacity is just 310 litres, whereas the 1.8 HEV boasts 388.
The good news? Toyota has done a terrific job of keeping the handling of this 1,645 kg but not too top-heavy crossover fairly benign. Performance is brisk (7.2 seconds to 62 mph), with excellent economy and CO2 averages. The 13.6 kWh battery allows not only a range of up to 41 miles but the PHEV will easily return 50+ mpg, with an official CO2 average of a mere 19 g/km.
Top speed is only 111 mph yet the C-HR charges there with the minimum of fuss and its naturally aspirated engine sounds quite good too. The stubby little RND shifter (P is a button) works perfectly first time every time. It's something of a shame to find the steering remains as light as it is in the HEV versions. Anyone trading up from a Yaris will notice slightly less precision.
Loud locking
I came to this Toyota after spending a bit of time with a Lexus UX hybrid and immediately the contrast between high-volume and something more exclusive was obvious. Interior plastics are mostly hard and heavy on the dark grey dye, while even things such as the way doors lock can jar. Really. I was startled the first time this happened as the thunk is LOUD. It probably doesn't help that all the handles retract at the same time. You'd get used to it though.
Something I really didn't like was the lack of a sunblind for the roof. Toyota, which states that this saves five kilos, will also insist that the UV-blocking dark filter is enough. It isn't. Speaking of glass, there is no wash-wipe on the back window and this car needs one. Right now, tree sap season has started, dropping vision-blocking gunk you can guess where.
Other ways in which TMC has decided to save money includes something I have seen in no other passenger vehicle: ceiling-mounted grab handles for driver and front passenger but none in the back. Will anyone notice? I did. There are countless reasons why this massively profitable car company stays that way.
No Icon model grade for the PHEV
The C-HR is no bargain basement model, with every variant above thirty thousand pounds. And, unlike the HEV, the PHEV is only available in Design, Excel and GR Sport trims. Quite a smart move by TGB to launch the model this way, watching to see what happens. So far the market has received the plug-in hybrid with enthusiasm. Its pricing will inevitably also draw potential buyers to the hybrids which suddenly seem more affordable.
Conclusion
If the near-premium pricing is acceptable, then the PHEV is going to tempt many a company car and private buyer towards the C-HR. There's a good level of standard gear, the looks are sharp, economy is superb and CO2 is low. Plus we know just how long-lasting and reliable Toyotas tend to be.
Next: the C-HR+
With close to a million sales in Europe across its two generations, the C-HR is certainly a well-known model. Which is likely the reason why Toyota is leveraging what it might term a brand for the addition of the forthcoming C-HR+. We first saw it as the bZ Compact SUV concept at the 2022 Los Angeles auto show.
It should be pointed out immediately that this an entirely unrelated vehicle being not only an EV but also 17 cm longer and having a different architecture (eTGNA). It's also going to be manufactured in Japan not Turkey. Build at the Takaoka factory is due to commence in September. The US and Canada will have the model in 2026 but no plant has been named.
Both 57.7 and 77 kWh gross batteries will be available as well as front- and all-wheel drive, the latter having two motors and an expected 252 kW (343 pferdestarke). There is also a provisional claim of up to 600 km or 373 miles ahead of the official WLTP rating."Why the C-HR is Toyota's secret weapon" was originally created and published by Just Auto, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Toyota, Subaru Hit with Class-Action Lawsuit Over Claims of 12-Volt Batteries in EVs That Keep Dying
A new lawsuit filed against Subaru and Toyota claims that the two automakers' jointly developed electric vehicles, the Solterra and bZ4X, suffers from an issue that causes the 12-volt battery used for accessories to repeatedly fail, with the plaintiff filing the suit claiming his vehicle has gone through multiple batteries in 5000 miles. The class-action lawsuit, which was filed in the U.S. Eastern District Court of California, claims that Subaru and Toyota both knew about 12-volt battery problems before the the Bz4X or Solterra went on sale. Allegedly, these cars (from the 2023–2025 model years) drain and kill the 12-volt battery on a regular basis; despite that, the suit claims the two carmakers failed to warn customers or to fix the issues at hand. The filing mainly focuses on this single owner's account. "The 12-volt battery equipped in Plaintiff Wade's Class Vehicle has failed three times after only about 5000 miles of driving the vehicle. The 12-volt battery in Plaintiff Wade's vehicle has been replaced twice since March 2023,"says the filing, according to The owner claims that the first failure happened within weeks of ownership; then the battery died again when it had around 2000 miles on it, and yet again around the 5000-mile mark. Based on other accounts posted online, however, he's not alone when it comes to 12-volt battery issues. As one person with a 2024 example of the Solterra told the National Highway Transportation Safety Administration: "I have had the car since December of 2024, the car was a new lease. The battery has failed twice — once in January, and again last week. When I took it to the dealership, they said they replaced the battery, the new battery is now doing the same thing." On Reddit, customers have been complaining about similar situations since early 2023. "At 6 months had the 12 volt battery replaced, now after 3 weeks getting low battery again," said one commenter. Another made a post in January alleging that since picking up the car in April of 2024, they've had a dead 12-volt battery three different times. Interestingly, it doesn't appear as though the lawsuit in question defines what the central issue is between the 12-volt battery and the rest of the system. In other words, it doesn't define what the core defect, is aside from the 12-volt battery dying prematurely. Whether or not that factors into the suit's outcome is yet to be seen. The electric Toyobaru siblings are hardly the only EVs to suffer from issues and allegations of problems with their 12-volt batteries in recent years. Back in 2021, Ford issued a service bulletin regarding a software problem that caused the Mustang Mach-E's 12-volt to drain while the car's propulsion battery was being charged, while earlier this year, an owner took to Reddit to claim that his 2021 Mach-E's 12-volt lost power and trapped his child in the vehicle. Meanwhile, back in 2023, Hyundai found owners of the Ioniq 5 complaining about unexpected 12-volt battery death, eventually pinning the problem down as one related to third-party applications pinging the car too frequently via Bluetooth. You Might Also Like You Need a Torque Wrench in Your Toolbox Tested: Best Car Interior Cleaners The Man Who Signs Every Car Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
5 hours ago
- USA Today
The HEMI is back: Citing customer feedback, Ram returns V8 HEMI engines to 1500 pickups
The HEMI is back: Citing customer feedback, Ram returns V8 HEMI engines to 1500 pickups Show Caption Hide Caption Detroit Free Press Car, Truck, Utility of the Year revealed Decades of work by Toyota and a bold new strategy from General Motors pay off with great vehicles, all priced in the heart of the market. Ram discontinued the HEMI engine in 2024, opting for a more powerful and fuel efficient inline six-cylinder engine. Citing customer sentiment, Ram CEO Tim Kuniskis said the brand would rerelease the V-8 HEMI engine in most of its pickup offerings. Kuniskis also noted a change in Ram's market approach, with an extensive focus on one-to-one retail sales with "real customers." A year after removing the HEMI, Ram is reintroducing its famous V-8 engine to its product lineup and unveiling a new logo to accompany it. At a preview event with automotive media, Ram CEO Tim Kuniskis said the HEMI is coming back to Ram trucks along with a new emblem that the brand is calling a "symbol of protest," featuring a ram's head jutting out of a V-8 engine block. Rams reequipped with the HEMI engines will be available for sale this summer, the company said, in the following Ram 1500 models: Tradesman, Big Horn, Express, Warlock, Laramie, Rebel (available later than other models), Limited and Longhorn. A year ago, Ram announced it would be discontinuing the HEMI V-8 engines in favor of a more fuel-efficient and powerful Hurricane twin-turbo inline six-cylinder engine. The hurricane engines also performed better under emissions regulations. That move, Kuniskis said, was a mistake. "Ram screwed up when we dropped the HEMI — we own it and we fixed it,' Kuniskis said in a statement. Both the Hurricane and HEMI engines will be available for buyers now, giving buyers a choice. Kuniskis said that the decision was informed by customer feedback. People were mad. Toyota Tundra recalls: Is Toyota's most expensive truck reliable or plagued with issues? "(Buyers) hate the fact that we took away the freedom of choice," Kuniskis said. "We as Americans, probably more so truck buyers, hate the fact that we said, 'This is the choice you get, this is the engine you're going to take.' " Kuniskis said Ram's market approach has changed to focus almost entirely on retail sales, pulling back on fleet and rental business. Kuniskis considers this the truest reflection of the automotive market, he said, referring to retail sales as "sales to real customers." As is common with Kuniskis, whose persona reflects Ram's brand identity as loud and unapologetic, he was quick to decry experts who hawk Ram's sales numbers. The decision to bring the HEMI back was made because he heard enough from people who were upset, not crafty data analytics. "At the end of each month, we count sales to customers, not statisticians or ideologues," Kuniskis said. "Data be damned — we raise our flag and let the HEMI ring free again!' added Kuniskis. Liam Rappleye covers Stellantis and the UAW. Contact him at LRappleye@
Yahoo
6 hours ago
- Yahoo
FDA approves YolTech's YOLT-101 for familial hypercholesterolemia
YolTech Therapeutics has received the US Food and Drug Administration (FDA) approval for its investigational new drug (IND) application for YOLT-101 to treat heterozygous familial hypercholesterolemia (HeFH). YOLT-101 is an in vivo base editing therapy designed to target proprotein convertase subtilisin/kexin type 9 (PCSK9). Its innovative approach lies in its potential to durably reduce blood low-density lipoprotein cholesterol (LDL-C) levels through a single-dose treatment. The technology behind YOLT-101 incorporates YolTech's adenine base editor, known as hpABE5, which consists of nCas and a new deaminase evolved from Hafnia paralvei. To deliver this therapeutic agent, the company employs an advanced lipid nanoparticle (LNP) delivery system. hpABE5 can perform precise A•T to G•C base conversions without inducing DNA double-strand breaks, thus minimising risks associated with chromosomal abnormalities and off-target effects. YolTech Therapeutics co-founder and CEO Yuxuan Wu stated: 'The FDA IND clearance marks a significant milestone for YolTech. In vivo gene editing represents a new generation of therapeutics — offering one-time, durable solutions for chronic and genetic diseases. 'We are committed to advancing breakthrough gene editing solutions that offer transformative benefits for patients living with severe genetic and cardiovascular diseases.' Currently under evaluation in an ongoing investigator-initiated trial (IIT), YOLT-101 has shown promising results with a favourable safety profile and substantial LDL-C–lowering effects. Familial hypercholesterolemia is a genetic disorder stemming from mutations affecting LDL metabolism-related genes such as LDLR, Apolipoprotein B (APOB) and PCSK9. Individuals suffering from FH typically experience elevated LDL-C levels, which contribute to a heightened risk of developing early-onset atherosclerotic cardiovascular diseases. "FDA approves YolTech's YOLT-101 for familial hypercholesterolemia" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
